Research Interests
Carrer With Us

Drug Metabolism/ Miscellaneous

  1. The Effects on Metabolic Clearance When Administering a Potent CYP3A Autoinducer with the Prototypic CYP3A Inhibitor, Ketoconazole. Ayan-Oshodi MA, Willis BA, Annes WF, Lowe SL, Friedrich S, de la Pena A, Zhang W, Brown T, Wise SD, Hall SD. Drug Metab Dispos. 2012 Jul 12.

  2. Limited antioxidant effect after consumption of a single dose of tomato sauce by young males, despite a rise in plasma lycopene. Lee CY, Isaac HB, Huang SH, Long LH, Wang H, Gruber J, Ong CN, Kelly RP, Halliwell B. Free Rad Res 2009 Jun;43(6):622-8

  3. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies. Li J, Lee L, Gong Y, Shen P, Wong SP, Wise SD, Yong EL. Assay Drug Dev Technol. 2009 Feb;7(1):80-9.

  4. Possible differential induction of phase 2 enzyme and antioxidant pathways by american ginseng, Panax quinquefolius. Lee LS, Wise SD, Chan C, Parsons TL, Flexner C, Lietman PS. J Clin Pharmacol. 2008 May;48(5):599-609. Epub 2008 Mar 4.

  5. Lack of effect of acute oral ingestion of vitamin C on oxidative stress, arterial stiffness or blood pressure in healthy subjects. Kelly RP, Poo Yeo K, Isaac HB, Lee CY, Huang SH, Teng L, Halliwell B, Wise SD. Free Radic Res. 2008 May;42(5):514-22.

  6. Cautions in the use of biomarkers of oxidative damage; the vascular and antioxidant effects of dark soy sauce in humans. Lee CY, Isaac HB, Wang H, Huang SH, Long LH, Jenner AM, Kelly RP, Halliwell B. Biochem Biophys Res Commun. 2006 Jun 9;344(3):906-11. Epub 2006 Apr 19. Erratum in: Biochem Biophys Res Commun. 2006 Jul 21;346(1):377.

  7. A review and assessment of potential sources of ethnic differences in drug responsiveness. Bjornsson TD, Wagner JA, Donahue SR, Harper D, Karim A, Khouri MS, Murphy WR, Roman K, Schneck D, Sonnichsen DS, Stalker DJ, Wise SD, Dombey S, Loew C. J Clin Pharmacol. 2003 Sep;43(9):943-67. Review.

  8. Quinidine does not affect the renal clearance of moxonidine. Wise SD, Chan C, Schaefer HG, He MM, Pouliquen IJ, Mitchell MI. Br J Clin Pharmacol. 2002 Sep;54(3):251-4.